AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇨🇮
AMLODIPINE BESILATE+IRBESARTAN in Côte d'Ivoire
4 products registered with AIRP — 0 active, 4 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| APROVASC 300MG/5MG COMPRIME BOITE DE 28 | E-2013-2014 | SANOFI-AVENTIS DE MEXICO S.A. | expired | 17 Jul 2023 |
| APROVASC 300MG/10MG COMPRIME BOITE DE 28 | E-2013-215 | SANOFI-AVENTIS DE MEXICO S.A. | expired | 17 Jul 2023 |
| APROVASC 5MG/150MG COMPRIME BOITE DE 28 | E-2013-216 | SANOFI-AVENTIS DE MEXICO S.A. | expired | 17 Jul 2023 |
| APROVASC 150MG/10MG COMPRIME BOITE DE 28 | E-2013-217 | SANOFI-AVENTIS DE MEXICO S.A. | expired | 17 Jul 2023 |
AMLODIPINE BESILATE+IRBESARTAN — AIRP Registration Details
AIRP (Côte d'Ivoire) has 4 registered products containing AMLODIPINE BESILATE+IRBESARTAN, of which 0 are currently active. Data is sourced directly from the official AIRP drug register and refreshed daily.
Track AMLODIPINE BESILATE+IRBESARTAN registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.